@article{c4ac6dad2c0245daae7e4d54ed8db990,
title = "Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the Danish Nationwide DANBIO Registry",
abstract = "To describe the frequency of treatment switching and outcomes among patients with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in routine care.",
keywords = "Adult, Antirheumatic Agents, Arthritis, Psoriatic, Cohort Studies, Denmark, Drug Substitution, Female, Health Status, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Recovery of Function, Registries, Remission Induction, Survival Rate, Treatment Outcome, Tumor Necrosis Factor-alpha",
author = "Bente Glintborg and Mikkel Ostergaard and Krogh, {Niels Steen} and Andersen, {Martin Dehn} and Ulrik Tarp and Loft, {Anne Gitte} and Lindegaard, {Hanne M} and Mette Holland-Fischer and Henrik Nordin and Jensen, {Dorte Vendelbo} and Olsen, {Christian Holkmann} and Hetland, {Merete Lund}",
note = "Copyright {\textcopyright} 2013 by the American College of Rheumatology.",
year = "2013",
doi = "10.1002/art.37876",
language = "English",
volume = "65",
pages = "1213--23",
journal = "Arthritis & Rheumatism",
issn = "0004-3591",
publisher = "Wiley",
number = "5",
}